SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation

BMC Surgery

Volumn 12, Issue , 2012, Pages

  Ruiterkamp, Jetske ^a   Voogd, Adri C ^b   Tjan Heijnen, Vivianne C G ^b   Bosscha, Koop ^c   Van Der Linden, Yvette M ^d   Rutgers, Emiel J T H ^e   Boven, Epie ^f   Van Der Sangen, Maurice J C ^g   Ernst, Miranda F ^b,c  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d Radiotherapeutic Institute Friesland   (Netherlands)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CATHARINA HOSPITAL   (Netherlands)

Author keywords

Primary metastatic breast cancer; randomised controlled trial; surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MASTECTOMY; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859122660     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-12-5     Document Type: Article

References (22)

1. Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands. Ruiterkamp J, Ernst MF, de Munck L, van der Heiden-van de Loo M, Bastiaannet E, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VCG, Voogd AC, Breast Cancer Res Treat 2011 128 495 503 10.1007/s10549-011-1349-x 21240629
2. Loco-regional treatment in metastatic breast cancer patients: Is there a survival benefit? Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G, Breast Cancer Res Treat 2010 119 537 545 10.1007/s10549-009-0610-z 19876731
3. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Chia SK, Speers CH, D'yachkova Y, et al. Cancer 2007 110 973 979 10.1002/cncr.22867 17647245 (Pubitemid 47312861)
4. Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Ernst MF, van de Poll-Franse LV, Roukema JA, et al. Breast 2002 16 344 351
5. Does aggressive local therapy improve survival in metastatic breast cancer? Khan SA, Stewart AK, Morrow M, Surgery 2002 132 620 627 10.1067/msy.2002.127544 12407345 (Pubitemid 35247324)
6. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Babiera GV, Rao R, Feng L, et al. Ann Surg Oncol 2005 13 776 782
7. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Rapiti E, Verkooijen HM, Vlastos G, et al. J Clin Oncol 2006 24 2743 2749 10.1200/JCO.2005.04.2226 16702580 (Pubitemid 46630571)
8. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Fields RC, Donna BJ, Trinkaus K, et al. Ann Surg Oncol 2007 14 12 3345 3351 10.1245/s10434-007-9527-0 17687611 (Pubitemid 350160108)
9. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer. Analysis of the 1988-2003 SEER data. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA, Ann Surg Oncol 2007 14 8 2187 2194 10.1245/s10434-007-9438-0 17522944 (Pubitemid 47174926)
10. Association of surgery with improved survival in stage IV breast cancer patients. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM, Ann Surg 2008 247 5 732 738 10.1097/SLA.0b013e3181656d32 18438108 (Pubitemid 351591506)
11. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC, Eur J Surg Oncol 2009 35 1146 1151 10.1016/j.ejso.2009.03.012 19398188
12. Stage IV breast cancer in the era of targeted therapy. Does surgery of the primary tumor matter? Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA, Cancer 2010 116 5 1226 1233 10.1002/cncr.24873 20101736
13. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Rao R, Feng L, Kuerer HM, et al. Ann Surg Oncol 2008 15 1696 1702 10.1245/s10434-008-9830-4 18357493
14. Impact of breast surgery on survival in patients with distant metastases at initial presentation. A systematic review of the literature. Ruiterkamp J, Voogd AC, Bosscha K, Tjan-Heijnen VCG, Ernst MF, Breast Cancer Res Treat 2010 120 1 9 16 10.1007/s10549-009-0670-0 20012891
15. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Cady B, Nathan NR, Michaelson JS, Golshan M, Smith BL, Ann Surg Oncol 2008 15 3384 3395 10.1245/s10434-008-0085-x 18726129
16. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Bafford AC, Burstein HJ, Barkley CR, Smith BL, Lipsitz S, Iglehart JD, Winer EP, Golshan M, Breast Cancer Res Treat 2009 115 7 12 10.1007/s10549-008-0101-7 18581232
17. Effects of surgical excision on survival of patients with stage IV breast cancer. Leung AM, Vu HN, Nguyen KA, Thacker LR, Bear HD, J Surg Res 2010 161 1 83 88 10.1016/j.jss.2008.12.030 19375721
18. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong Y, Carter B, Javid S, Edge S, Burstein H, Golshan Mehra, Breast Cancer Res Treat 2011
19. Sequential treatment assignment with balancing of prognostic factors in controlled clinical trials. Pocock S, Simon R, Biometrics 1975 31 103 115 10.2307/2529712 1100130
20. http://www.wma.net/en/30publications/10policies/b3/index.html
21. Repeated assessment of results in clinical trials of cancer treatment. Haybittle JL, Br J Radiol 1971 44 793 797 10.1259/0007-1285-44-526-793 4940475
22. Design and analysis of randomized clinical trials requiring prolonged observation or each patient. Peto R, Pike MC, Armitage P, et al. Br J Cancer 1976 34 585 612 10.1038/bjc.1976.220 795448 (Pubitemid 8004970)